Lurakem Study Quiz Link

Approved & Edited by ProProfs Editorial Team

The editorial team at ProProfs Quizzes consists of a select group of subject experts, trivia writers, and quiz masters who have authored over 10,000 quizzes taken by more than 100 million users. This team includes our in-house seasoned quiz moderators and subject matter experts. Our editorial experts, spread across the world, are rigorously trained using our comprehensive guidelines to ensure that you receive the highest quality quizzes.

Learn about Our Editorial Process

| By SUJIT

SUJIT

Community Contributor

Quizzes Created: 1 | Total Attempts: 98

Questions: 10 | Attempts: 98 | Updated: Jun 17, 2023

Questions

Settings

Feedback

During the Quiz End of Quiz

Difficulty

Sequential Easy First Hard First

Play as

Quiz Flashcard

Create your own Quiz

Share on Facebook Share on Twitter Share on Whatsapp Share on Pinterest Share on Email Copy to Clipboard Embed on your website

Questions and Answers

1.

For which indication was the recent approval of Lurasidone from USFDA?
- A.
  
  For schizophrenia aged between 13-17
- B.
  
  For Bipolar disorder & schizophrenia aged between 13-17
- C.
  
  For adolescent schizophrenia aged between 13-17
- D.
  
  For Bipolar depression aged between 13-17
Correct Answer
C. For adolescent schizopHrenia aged between 13-17

Explanation
The recent approval of Lurasidone from USFDA was for the indication of adolescent schizophrenia aged between 13-17.

Rate this question:
2.

In which journal(Name of the journal) the lurasidone safety & effectiveness got proved in 2 years of study?
- A.
  
  International journal of bipolar disorder 2017
- B.
  
  Bipolar journal psychiatry & mood disorders 2016
- C.
  
  BPD psychiatry 2017
- D.
  
  Indian Journal of Psychiatry disorders 2016
Correct Answer
A. International journal of bipolar disorder 2017

Explanation
The correct answer is the International Journal of Bipolar Disorder 2017.

Rate this question:
3.

In the long term use of lurasidone trail over 2 years, change in weight gain, BMI,glycemic indices & prolactin with lurasidone were not meaningful?
- A.
  
  True
- B.
  
  False
Correct Answer
A. True

Explanation
The statement suggests that in a long-term study of lurasidone, there were no significant changes observed in weight gain, BMI, glycemic indices, and prolactin levels. This implies that the use of lurasidone over a period of 2 years did not have a meaningful impact on these factors. Therefore, the answer "True" indicates that the statement is correct.

Rate this question:
4.

In this safety & efficacy trail of 2 years with lurasidone discontinuation due to adverse events with lurasidone was relatively low as 6.6% ?
- A.
  
  True
- B.
  
  False
Correct Answer
A. True

Explanation
The explanation for the given correct answer is that in a safety and efficacy trial conducted over a period of 2 years with lurasidone, the discontinuation rate due to adverse events was relatively low at 6.6%. This suggests that the participants in the trial were able to tolerate the medication well and did not experience significant adverse effects that would require them to discontinue its use. Therefore, the statement that discontinuation due to adverse events with lurasidone was relatively low as 6.6% is true.

Rate this question:
5.

In the safety & efficacy study of lurasidone in long term, Lurasidone has high relapse rates.?
- A.
  
  True
- B.
  
  False
Correct Answer
B. False

Explanation
The statement "Lurasidone has high relapse rates" is false. This means that in the safety and efficacy study of lurasidone in the long term, lurasidone did not show high relapse rates.

Rate this question:
6.

Name of the journal where the NMA(Network Meta Analysis) of Lurasidone Vs other antipsychotics was published?
- A.
  
  World Health Organisation 2017
- B.
  
  World Journal of Biological psychiatry 2017
- C.
  
  Bipolar disorder 2017
- D.
  
  International journal of bipolar disorder 2017
Correct Answer
B. World Journal of Biological psychiatry 2017

Explanation
The correct answer is "World Journal of Biological psychiatry 2017". This journal is likely to be the one where the NMA of Lurasidone Vs other antipsychotics was published, as it specifically focuses on biological psychiatry and publishes research in this field.

Rate this question:
7.

Full form of CGI-BPS.?
- A.
  
  Clinical global impression - blood pressure scale
- B.
  
  Clinical global impression - bipolar scale
- C.
  
  Clinical global impression - binary scale
- D.
  
  Clinical global impression -British pharmacopoeia
Correct Answer
B. Clinical global impression - bipolar scale

Explanation
CGI-BPS stands for Clinical Global Impression - Bipolar Scale. This scale is used in clinical research and practice to assess the severity of illness and overall improvement in patients with bipolar disorder. It involves rating the patient's condition on a scale from 1 to 7, with 1 indicating normal, not ill, and 7 indicating extremely ill. The CGI-BPS helps clinicians and researchers in evaluating the effectiveness of treatments and tracking the progress of patients with bipolar disorder.

Rate this question:
8.

In the NMA study lurasidone had better efficacy compared to Aripiprazole & Ziprasidone.?
- A.
  
  True
- B.
  
  False
Correct Answer
A. True

Explanation
The NMA study found that lurasidone had better efficacy compared to both Aripiprazole and Ziprasidone. This suggests that lurasidone was more effective in treating the condition or symptoms being studied than the other two medications.

Rate this question:
9.

In the NMA study Olanzapine & Quetiapine had lesser weight gain compared to Lurasidone.?
- A.
  
  True
- B.
  
  False
Correct Answer
B. False

Explanation
The given statement is false. The NMA study shows that Olanzapine & Quetiapine had greater weight gain compared to Lurasidone.

Rate this question:
10.

In the NMA study lurasidone was having less somnolence compared to Quetiapine & Ziprasidone.?
- A.
  
  True
- B.
  
  False
Correct Answer
A. True

Explanation
The NMA study found that lurasidone had less somnolence compared to both Quetiapine and Ziprasidone. This means that lurasidone is associated with less drowsiness or sleepiness as a side effect compared to the other two medications. Therefore, the statement "lurasidone was having less somnolence compared to Quetiapine & Ziprasidone" is true based on the findings of the NMA study.

Rate this question:

Quiz Review Timeline +

Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.

Current Version
Jun 17, 2023

Quiz Edited by
ProProfs Editorial Team
Jun 14, 2017

Quiz Created by
SUJIT

Lurakem Study Quiz Link

For which indication was the recent approval of Lurasidone from USFDA?

In which journal(Name of the journal) the lurasidone safety & effectiveness got proved in 2 years of study?

In the long term use of lurasidone trail over 2 years, change in weight gain, BMI,glycemic indices & prolactin with lurasidone were not meaningful?

In this safety & efficacy trail of 2 years with lurasidone discontinuation due to adverse events with lurasidone was relatively low as 6.6% ?

In the safety & efficacy study of lurasidone in long term, Lurasidone has high relapse rates.?

Name of the journal where the NMA(Network Meta Analysis) of Lurasidone Vs other antipsychotics was published?

Full form of CGI-BPS.?

In the NMA study lurasidone had better efficacy compared to Aripiprazole & Ziprasidone.?

In the NMA study Olanzapine & Quetiapine had lesser weight gain compared to Lurasidone.?

In the NMA study lurasidone was having less somnolence compared to Quetiapine & Ziprasidone.?